Patents by Inventor Adilya Rafik kyzy Musaeva

Adilya Rafik kyzy Musaeva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090011041
    Abstract: The present invention relates to anti-aging pharmacology and is intended for correction of age-related changes in human endocrine system. The essence of the invention is the compositions for correction of certain age-related endocrine changes and method for production of pharmaceutical form based thereon. Each composition contains a mixture of substances exhibiting hormonal activity (HA) or hormone-like activity (HLA) selected from the group: C21 or C19 steroids, pregnenolone, 17-hydroxypregnenolone, DHEA, progesterone, testosterone, or a hormone-like substance of herbal origin (HS), and also a dry methanolic of Nettle root extract, taken in a definite ratio, wherein HA, HLA or HS with the Nettle root extract can further contain a Deer Antler velvet extract and/or Ginseng root extract, and HS can comprise diosgenin or protodioscin. One variant of the composition is a mixture of a dry Ginseng root extract and a dry Nettle root extract.
    Type: Application
    Filed: April 4, 2005
    Publication date: January 8, 2009
    Inventors: Adilya Rafik kyzy Musaeva, Olga Vyacheslavovna Smirnova, Irina Nikolaevna Kuzina, Roman Lvovich Bogorad, Irina Olegovna Perminova
  • Publication number: 20080057113
    Abstract: A new anti-herpetic composition is proposed which comprises a virion preparation containing herpes simplex viruses of serotypes 1 and 2 inactivated by formalin or ?-irradiation; the composition further comprises a hi-tech immunomodulator Polyoxidonium, and also amino acids valine and lysine, as well as a combination consisting of at least two amino acids selected from the group: phenylalanine, leucine, alanine, threonine, histidine, arginine, methionine, and can also comprise isoleucine, which is able to stimulate the formation of anti-herpetic peptides at the cell level. The composition can be formulated into various pharmaceutical forms, and owing to its properties it can be used not only in the case of acute, but also in the case of chronic herpetic pathology.
    Type: Application
    Filed: October 20, 2004
    Publication date: March 6, 2008
    Inventors: Adilya Rafik kyzy Musaeva, Igor Feliksovich Barinsky, Alla Arnoldovna Lazarenko, Rem Victorovich Petrov, Rakhim Musaevich Khaitov, Musa Rakhimovich Khaitov